These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26343823)

  • 21. An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines : A report for the National Osteoporosis Guideline Group (NOGG).
    Kanis JA; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; McCloskey EV
    Osteoporos Int; 2021 Oct; 32(10):1951-1960. PubMed ID: 33813622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines.
    Baddoura R; Awada H; Okais J; Salamoun M; Ayoub G; Ziadé N; El Hajj-Fuleihan G
    Osteoporos Int; 2006; 17(7):1111-5. PubMed ID: 16758146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Usefulness of FRAX and future issues in women's health].
    Hashimoto K; Ishitani K; Ohta H
    Clin Calcium; 2009 Dec; 19(12):1742-8. PubMed ID: 19949265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical decision support system for the management of osteoporosis compared to NOGG guidelines and an osteology specialist: a validation pilot study.
    Gudmundsson HT; Hansen KE; Halldorsson BV; Ludviksson BR; Gudbjornsson B
    BMC Med Inform Decis Mak; 2019 Feb; 19(1):27. PubMed ID: 30709348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study.
    Berry SD; Kiel DP; Donaldson MG; Cummings SR; Kanis JA; Johansson H; Samelson EJ
    Osteoporos Int; 2010 Jan; 21(1):53-60. PubMed ID: 19937426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of FRAX as a determinant for risk-based osteoporosis screening may decrease unnecessary testing while improving the odds of identifying treatment candidates.
    Edwards FD; Grover ML; Cook CB; Chang YH
    Womens Health Issues; 2014; 24(6):629-34. PubMed ID: 25128036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an opportunistic diagnostic prediction algorithm for osteoporosis and fragility fracture risk estimates from forearm radiographs (The OFFER1 Study).
    Meertens R; Lopez B; Crone B; Gundry M; Metcalfe-Smith E; Gibbard W; Jubb T; Manning F; Scott P; McWilliam R
    JBMR Plus; 2024 Apr; 8(4):ziae020. PubMed ID: 38505820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of Glucocorticoid-Induced Osteoporosis: Clinical audit to evaluate the implementation of National Osteoporosis Guideline Group 2017 guidelines in a primary care setting.
    Carter M
    J Clin Densitom; 2019; 22(1):25-30. PubMed ID: 29729949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and Management of Osteoporosis: A Comprehensive Review of Guidelines.
    Rentzeperi E; Pegiou S; Tsakiridis I; Kalogiannidis I; Kourtis A; Mamopoulos A; Athanasiadis A; Dagklis T
    Obstet Gynecol Surv; 2023 Nov; 78(11):657-681. PubMed ID: 38134337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec.
    Vanasse A; Dagenais P; Niyonsenga T; Grégoire JP; Courteau J; Hemiari A
    BMC Musculoskelet Disord; 2005 Jun; 6():33. PubMed ID: 15969760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragility fracture risk in cirrhosis: a comparison of the fracture risk assessment tool, British Society of Gastroenterology and National Institute for Health and Clinical Excellence guidelines.
    Ayres LRO; Clarke S; Digby-Bell J; Dhanda AD; Dharmasiri S; Caddick K; Collins PL
    Frontline Gastroenterol; 2012 Oct; 3(4):220-227. PubMed ID: 28839671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.
    Lim LS; Hoeksema LJ; Sherin K;
    Am J Prev Med; 2009 Apr; 36(4):366-75. PubMed ID: 19285200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for osteoporosis using easily obtainable biometrical data: diagnostic accuracy of measured, self-reported and recalled BMI, and related costs of bone mineral density measurements.
    van der Voort DJ; Brandon S; Dinant GJ; van Wersch JW
    Osteoporos Int; 2000; 11(3):233-9. PubMed ID: 10824239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass.
    Zhang J; Delzell E; Curtis JR; Hooven F; Gehlbach SH; Anderson FA; Saag KG
    Osteoporos Int; 2014 Jan; 25(1):317-24. PubMed ID: 23982799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation.
    Feldstein A; Elmer PJ; Orwoll E; Herson M; Hillier T
    Arch Intern Med; 2003 Oct; 163(18):2165-72. PubMed ID: 14557214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for the early detection of osteoporosis and prediction of fracture risk. Council of the National Osteoporosis Foundation.
    S Afr Med J; 1996 Sep; 86(9):1113-6. PubMed ID: 8888782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there an interaction between socioeconomic status and FRAX 10-year fracture probability determined with and without bone density measures? Data from the Geelong Osteoporosis Study of female cohort.
    Brennan SL; Quirk SE; Hosking SM; Kotowicz MA; Holloway KL; Moloney DJ; Dobbins AG; Pasco JA
    Calcif Tissue Int; 2015 Feb; 96(2):138-44. PubMed ID: 25578145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines.
    Wang CC; Wu CH; Farley JF
    Ann Pharmacother; 2015 Sep; 49(9):995-1003. PubMed ID: 26041809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct; 155(8):1113-33. PubMed ID: 8873639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.